2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Poster

1.229 - Expression of receptors for anaphylatoxins C3a and C5a on islet preparations

Presenter: K. , Tokodai, ,
Authors: K. Tokodai, M. Goto, A. Inagaki, W. Nakanishi, S. Satomi

P-229 Poster of distinction

Expression of receptors for anaphylatoxins C3a and C5a on islet preparations

K. Tokodai, M. Goto, A. Inagaki, W. Nakanishi, S. Satomi
Tohoku University, Sendai, Japan

Objective: Complement activation has been implicated in the development of the instant blood-mediated inflammatory reaction (IBMIR). Especially anaphylatoxins C3a and C5a elicit a broad range of pro-inflammatory effects including chemotaxis of inflammatory cells and cytokine release. We have shown that 2 types of receptors for C5a are expressed on isolated islets (Transplantation:2010:90:1358-1365). In the present study, we investigated this component in detail.
Methods: C3aR, C5aR and C5L2, together with CD11b and CD31, on freshly isolated islets (fresh group) and islets cultured with (cytokine group) or without (culture group) TNF-?, IL1-?, and IFN-? for about 12 h were analyzed by flow cytometry. In addition, these 3 kinds of receptors on nonendocrine cells were also analyzed.
Results: C5aR and C5L2 were expressed on the isolated islets (C5aR: 7.91 ± 2.83%, C5L2: 2.45 ± 1.34%, respectively) and the expression of both C5a receptors was markedly attenuated by cultured for 12 h (C5aR: p<0.005, C5L2: p<0.05, respectively). Compared with the culture group, the expression was significantly up-regulated in the cytokine group (C5aR: p<0.05, C5L2: p=0.05, respectively). C5aR positive cells expressed CD11b, but not CD31. Contrary to islets, nonendocrine cells expressed C5L2 predominantly (C5aR: 1.51 ± 0.87%, C5L2: 4.58 ± 2.19%). C3aR was scarcely expressed on the isolated islets or nonendocrine cells.
Conclusions: These data suggest that C5aR and C5L2 are expressed on CD11b positive leukocytes in islet preparations. Depletion of C5a receptors by culturing appropriately could be an attractive therapeutic strategy in clinical islet transplantation.

/

P-229 Poster of distinction

Expression of receptors for anaphylatoxins C3a and C5a on islet preparations

K. Tokodai, M. Goto, A. Inagaki, W. Nakanishi, S. Satomi
Tohoku University, Sendai, Japan

Objective: Complement activation has been implicated in the development of the instant blood-mediated inflammatory reaction (IBMIR). Especially anaphylatoxins C3a and C5a elicit a broad range of pro-inflammatory effects including chemotaxis of inflammatory cells and cytokine release. We have shown that 2 types of receptors for C5a are expressed on isolated islets (Transplantation:2010:90:1358-1365). In the present study, we investigated this component in detail.
Methods: C3aR, C5aR and C5L2, together with CD11b and CD31, on freshly isolated islets (fresh group) and islets cultured with (cytokine group) or without (culture group) TNF-?, IL1-?, and IFN-? for about 12 h were analyzed by flow cytometry. In addition, these 3 kinds of receptors on nonendocrine cells were also analyzed.
Results: C5aR and C5L2 were expressed on the isolated islets (C5aR: 7.91 ± 2.83%, C5L2: 2.45 ± 1.34%, respectively) and the expression of both C5a receptors was markedly attenuated by cultured for 12 h (C5aR: p<0.005, C5L2: p<0.05, respectively). Compared with the culture group, the expression was significantly up-regulated in the cytokine group (C5aR: p<0.05, C5L2: p=0.05, respectively). C5aR positive cells expressed CD11b, but not CD31. Contrary to islets, nonendocrine cells expressed C5L2 predominantly (C5aR: 1.51 ± 0.87%, C5L2: 4.58 ± 2.19%). C3aR was scarcely expressed on the isolated islets or nonendocrine cells.
Conclusions: These data suggest that C5aR and C5L2 are expressed on CD11b positive leukocytes in islet preparations. Depletion of C5a receptors by culturing appropriately could be an attractive therapeutic strategy in clinical islet transplantation.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada